Price Alert

Novartis AG (NVS)

NYSE: NVS · Real-Time Price · USD

123.58

1.49 (1.22%)

At close: Aug 15, 2025, 12:14 PM

Novartis Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	54.63B	52.86B	51.07B	49.29B	48.21B	49.63B	51.01B	52.32B	53.07B	52.22B	51.83B	52.26B	52.79B	53B	52.88B	52.38B	51.56B	49.88B
Cost of Revenue	9.79B	13B	12.9B	12.6B	12.49B	13.61B	14.41B	15.46B	16.15B	15.56B	15.49B	15.39B	15.52B	15.68B	15.87B	16.11B	15.92B	15.44B
Gross Profit	30.58B	39.86B	38.17B	36.69B	35.72B	36.02B	36.6B	36.86B	36.92B	36.66B	36.34B	36.87B	37.27B	37.31B	37.01B	36.28B	35.63B	34.45B
Operating Income	16.57B	15.75B	14.71B	13.77B	11.9B	10.89B	10.12B	9.49B	9.89B	9.2B	9.2B	9.81B	10.88B	12.13B	11.69B	11.77B	10.95B	9.82B
Interest Income	504M	579M	568M	517M	713M	713M	811M	571M	555M	496M	412M	242M	36M	20M	n/a	n/a	n/a	n/a
Pretax Income	15.68B	14.92B	13.67B	12.76B	10.93B	9.86B	9.44B	8.8B	9.17B	8.44B	8.37B	23.58B	24.89B	26.36B	26.14B	11.74B	10.93B	9.71B
Net Income	9.62B	12.86B	11.94B	17.6B	16.18B	15.24B	14.85B	7.84B	7.65B	7.03B	6.96B	21.8B	22.98B	24.18B	24.02B	9.81B	8.98B	7.96B
Selling & General & Admin	9.7B	12.78B	12.57B	12.51B	12.47B	13.06B	13.66B	13.97B	14.29B	14.18B	14.25B	14.49B	14.7B	14.87B	14.89B	14.82B	14.63B	14.24B
Research & Development	7.6B	9.88B	9.74B	9.46B	11B	11.25B	11.81B	11.69B	10.5B	10.47B	10B	9.96B	9.61B	9.51B	9.54B	9.46B	9.23B	9.27B
Other Expenses	1.45B	1.45B	1.15B	785M	n/a	463M	647M	1.52B	2.24B	2.81B	2.9B	2.61B	2.09B	809M	895M	217M	827M	1.11B
Operating Expenses	18.75B	24.11B	23.45B	22.92B	23.82B	25.13B	26.48B	27.37B	27.03B	27.46B	27.14B	27.06B	26.39B	25.19B	25.32B	24.51B	24.68B	24.62B
Interest Expense	840.29M	1.09B	1.04B	948M	906M	884M	863M	865M	858M	836M	837M	824M	811M	810M	811M	806M	813M	832M
Selling & Marketing Expenses	3.44M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	38.06B	37.11B	36.36B	35.52B	36.31B	38.74B	40.89B	42.84B	43.18B	43.02B	42.63B	42.45B	41.91B	40.87B	41.19B	40.61B	40.61B	40.06B
Income Tax Expense	1.46B	2.06B	1.7B	975M	814M	671M	676M	1.21B	1.52B	1.41B	1.42B	1.79B	1.91B	2.18B	2.12B	1.93B	1.94B	1.75B
Shares Outstanding (Basic)	1.95B	1.97B	1.99B	2.01B	2.03B	2.04B	2.05B	2.06B	2.08B	2.11B	2.13B	2.17B	2.2B	2.23B	2.24B	2.24B	2.24B	2.25B
Shares Outstanding (Diluted)	1.96B	1.98B	2B	2.03B	2.05B	2.06B	2.06B	2.08B	2.1B	2.12B	2.15B	2.18B	2.21B	2.24B	2.25B	2.25B	2.26B	2.27B
EPS (Basic)	6.94	6.43	5.92	8.64	7.91	7.42	7.19	3.74	3.62	3.28	3.19	9.79	10.29	10.81	10.72	4.35	3.97	3.50
EPS (Diluted)	6.89	6.39	5.88	8.58	7.86	7.38	7.15	3.72	3.59	3.25	3.16	9.72	10.22	10.73	10.65	4.33	3.95	3.48
EBITDA	16.64B	21.88B	20.75B	19.76B	19.04B	18.61B	18.86B	18.57B	16.8B	16.03B	15.36B	15.5B	17.04B	17.91B	17.72B	17.9B	17.37B	16.48B
EBIT	11.89B	15.97B	14.65B	13.68B	11.8B	10.71B	10.31B	9.68B	10.04B	9.29B	9.21B	24.41B	25.7B	27.17B	26.95B	12.55B	11.74B	10.54B
Depreciation & Amortization	4.75B	5.91B	6.07B	6.03B	7.17B	7.84B	8.52B	8.88B	7.79B	7.77B	7.18B	6.75B	6.18B	5.82B	6.11B	6.21B	6.49B	6.75B